Concepedia
Statistics
Publications
26
Citations
3.3K
H-Index
21
Active since
1996
Affiliations
Eli Lilly (United States)(Current)
Indiana University – Purdue University Indianapolis
Indiana University School of Medicine
Scripps Research Institute
Pennington Biomedical Research Center
Keith R. Stayrook is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and cell biology.
Top concepts
MedicineCell BiologyPharmacologyBiochemistryMolecular BiologySignal TransductionHealthPhysiologyCell SignalingNatural Sciences
Publications per year
1996–2021
Identification of heme as the ligand for the orphan nuclear receptors REV-ERBα and REV-ERBβ
Srilatha Raghuram, Keith R. Stayrook, Pengxiang Huang et al. · Nature Structural & Molecular Biology · 2007 · 548 citations · Full text
Orphan Nuclear Receptors, Signal Transduction, Receptor (Biochemistry) +8
Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice
Emily Farrow, Xijie Yu, Lelia J. Summers et al. · Proceedings of the National Academy of Sciences · 2011 · 367 citations · Full text
Antidiabetic Action of a Liver X Receptor Agonist Mediated By Inhibition of Hepatic Gluconeogenesis
Guoqing Cao, Liang Yu, Carol L. Broderick et al. · Journal of Biological Chemistry · 2003 · 291 citations · Full text
Liver X Receptor, Insulin Signaling, Oxidative Stress +22
Regulation of Carbohydrate Metabolism by the Farnesoid X Receptor
Keith R. Stayrook, Kelli Bramlett, Rajesh S. Savkur et al. · Endocrinology · 2004 · 286 citations · Full text
Farnesoid X Receptor, Cholangiopathies, Gastrointestinal Peptide Hormone +16
Prenylation of oncogenic human PTPcaax protein tyrosine phosphatases
Carolyn A. Cates, Rodney L. Michael, Keith R. Stayrook et al. · Cancer Letters · 1996 · 209 citations
Signal Transduction, Biochemistry, Natural Sciences +5
1–5 of 26